Clinical trial Recruiting at 2 sites Observational Ages 18 to 45 Women only

Investigating blood and tissue markers for diagnosing endometriosis

Official title: Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. a Prospective Multicenter Nationwide Study. (ENDOBIO)

Run by Region Stockholm · NCT05339451 · Data updated 2026-11-12

This study is trying to find blood and tissue markers that can help doctors diagnose endometriosis earlier and more accurately in women who are having surgery for suspected cases.

More Endometriosis trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment345 (estimated)
SponsorRegion Stockholm
Government
Locations3 sites (Stockholm, Huddinge and 2 other locations)
StatusRecruiting
StartedMay 4, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedFebruary 24, 2025
Trial IDNCT05339451 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18-45 who are undergoing surgery for suspected endometriosis or other benign gynecological issues.

Probably not a fit

Patients who are postmenopausal, have a BMI over 40, or have certain other medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify and validate biomarkers associated with endometriosis to improve diagnosis and prognosis. It will involve women of reproductive age who are undergoing laparoscopic surgery for suspected endometriosis or other benign gynecological conditions. The study will analyze blood and tissue samples to correlate these biomarkers with clinical manifestations, relapse rates, and fertility outcomes. The goal is to develop a laboratory test that can facilitate earlier and more accurate diagnosis of endometriosis.

Why it matters

Potential benefit: If successful, this study could lead to earlier diagnosis and better management of endometriosis, reducing the time patients suffer before receiving appropriate care.

How similar studies have gone: While there have been studies exploring biomarkers in endometriosis, this specific approach to validate them for diagnosis and prognosis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
IInclusion Criteria:

* women of reproductive age (18-45) who are operated because of suspected endometriosis (dysmenorrhea, dyspareunia, infertility, etc.) (patient group)
* women of reproductive age (18-45) who are operated for other benign gynecological causes with laparoscopy (ovarian cysts, sterilization, fibroids, etc.) and are found without macroscopic endometriosis perioperatively and confirmed with blind biopsies (control group
* talk swedish or english in order to complete questionnaires and give informed consent for their participation in the study.

Exclusion Criteria:

* BMI\> 40
* postmenopausal women
* premature ovarian failure
* pelvic inflammatory disease (PID)
* current or previous malignancy
* pregnancy and 6 months postpartum
* corticosteroids in the last 3 months
* pituitary, kidney, liver, adrenal disease
* endometrial hyperplasia or endometrial polyp
* cardiovascular or systemic inflammatory diseases.

Where it's running

  • Karolinska Universitetssjukhus Huddinge
    Stockholm, Huddinge, Sweden
    Recruiting
  • Södersjukhuset Kvinnokliniken
    Stockholm, Stockholm County, Sweden
    Recruiting
  • Akademiska Uppsala
    Uppsala, Sweden
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.